Synvista Therapeutics, Inc. (SYNI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 14, 2025
Synvista Therapeutics Revenue
Synvista Therapeutics had revenue of $772.00 in the quarter ending September 30, 2008, a decrease of -27.58%. This brings the company's revenue in the last twelve months to $54.73K, down -51.63% year-over-year. In the year 2007, Synvista Therapeutics had annual revenue of $51.07K, down -17.73%.
Revenue (ttm)
54.73K
Revenue Growth
-51.63%
P/S Ratio
0.00
Revenue / Employee
6.08K
Employees
9
Market Cap
3.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2007 | 51.07K | -11.00K | -17.73% |
Dec 31, 2006 | 62.07K | -37.93K | -37.93% |
Dec 31, 2005 | 100.00K | -51.82K | -34.13% |
Dec 31, 2004 | 151.82K | - | - |
Dec 31, 2003 | - | - | - |
Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1998 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |